Thai tech startup Amity to use Singapore as a hub for its global expansion ambitions Singapore Economic Development Board (EDB) Source…
Visitors listen to an explanation of Fadu’s Gen. 6 technology at the 2026 OCP Korea Tech Day at COEX in…
Investre doubles down on Luxembourg as tokenisation ambitions attract new funding Luxembourg Times Source link
Today’s theme: ‘Blind Ambitions Abound’— and Unbound. A special edition going into the 250th July 4th weekend of the founder-led…
Sovereign AI company 1001, with operations across the GCC and London, has secured $30 million in a Series A funding…
The city-state will be the group’s regional headquarters and house its AI research centre [SINGAPORE] Amity Group, a South-east Asian…
Tech companies are cutting workers at a pace that has already pushed 2026 past 100,000 layoffs, and AI is now…
SUMMARY Revenue surged 48% to ₹2,086 Cr in FY26 as Square Yards posted ₹176 Cr in positive EBITDA, strengthening its…
Krutrim, India’s first GenAI unicorn, is shifting from AI model development to cloud services after months of relative quiet on…
Meta just acquired Assured Robot Intelligence, a humanoid robotics startup, marking the tech giant’s boldest move yet into physical AI.…
Meta has acquired humanoid robotics startup Assured Robot Intelligence for an undisclosed sum, the social media giant said. “We acquired…
Meta has acquired humanoid robotics startup Assured Robot Intelligence (ARI) for an undisclosed sum, the social media giant said. “We…
Inside the great AI talent war draining startups, powering Big Tech’s ambitions Invezz Source link
Inside the great AI talent war draining startups, powering Big Tech’s ambitions Invezz Source link
Inside the great AI talent war draining startups, powering Big Tech’s ambitions Invezz Source link
Inside the great AI talent war draining startups, powering Big Tech’s ambitions Invezz Source link
The global race to dominate artificial intelligence is increasingly defined not just by capital investment or computing power, but by…
The next frontier for cell therapy is shaping up to be in vivo treatments for autoimmune disease, and Eli Lilly…
